Join a study at NIH
For more information on trials listed below, or to learn about other available opportunities to participate in research studies, call the NIH Clinical Center Office of Patient Recruitment 1- 866-444-2214, TTY: 1-866-411-1010. Or email firstname.lastname@example.org. Se habla español.
NIAAA seek volunteers who are dependent on opioids like heroin, hydrocodone, fentanyl, methadone or oxycodone and are receiving or not receiving treatment for their addiction. The purpose of this research study is to learn how opiate use disorder affects dopamine signaling in the brain. This is not a treatment study for addiction. Refer to study 17-AA-0114.
Are you a heavy drinker? NIAAA researchers are seeking research volunteers for a study testing a medication that may reduce cravings for alcohol. There is an inpatient stay for approximately 3-4 weeks. Compensation is provided. Refer to study 16-AA-0080.
NIDDK seeks healthy normal weight men, 18-35, to participate in a research study. Doctors want to learn how the body burns energy at different temperatures. Participants will have a 17-day inpatient stay in the Metabolic Clinical Research Unit of the Clinical Center with weekends off. Compensation is provided. Refer to study 3-DK-0200 cohort 2.
NCI researchers are enrolling participants, 6 years and older, with alveolar soft part sarcoma into a new research study testing if an immunotherapy drug called atezolizumab is able to shrink the cancer. Refer to study 17-C-0074.
Food allergy? NIAID researchers are seeking volunteers 2 and older who have at least one food allergy to participate in a study to better understand how food allergies affect health. Participants receive a comprehensive nutritional evaluation and meet with a dietitian for individualized counseling. Compensation for participation is provided. Refer to study 15-I-0162.
Researchers are conducting a research study on CLN3, Batten disease a neurodegenerative disease, with typical onset in children to identify markers of disease and to better understand CLN3 and how it develops over time. If you have Juvenile Neuronal Ceroid Lipofuscinosis, (CLN3, Batten disease), you may be eligible. Study-related tests and procedures are provided at no cost. Refer to study # 18-CH-0002.
NCI researchers are currently enrolling people with smoldering multiple myeloma (SMM) to test the combination of carfilzomib, lenalidomide, and dexamethasone as to their safety and effectiveness in treating SMM. Refer to study 12-C-0107.
NHLBI researchers are testing ways to make stem cell transplant safer and more effective in people with severe aplastic anemia (SAA) and myelodysplastic syndrome (MDS). Refer to study 17-H-0091.